Published in
Wiley Open Access, Cancer Medicine, 6(12), p. 7077-7089, 2022
DOI: 10.1002/cam4.5506
Links
Tools
Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first‐line treatment for unresectable hepatocellular carcinoma
Journal article published in 2022 by
Chung‐Wei Su 
,
Wei Teng ,
Po‐Ting Lin,
Wen‐Juei Jeng ,
Kuei‐An Chen,
Yi‐Chung Hsieh ,
Wei‐Ting Chen,
Ming‐Mo Ho,
Chia‐Hsun Hsieh,
Ching‐Ting Wang,
Pei‐Mei Chai,
Chen‐Chun Lin,
Chun‐Yen Lin ,
Shi‐Ming Lin
,
Wei Teng ,
Po‐Ting Lin,
Wen‐Juei Jeng ,
Kuei‐An Chen,
Yi‐Chung Hsieh ,
Wei‐Ting Chen,
Ming‐Mo Ho,
Chia‐Hsun Hsieh,
Ching‐Ting Wang,
Pei‐Mei Chai,
Chen‐Chun Lin,
Chun‐Yen Lin ,
Shi‐Ming Lin
This paper is made freely available by the publisher.
Full text: Download
Data provided by 